SYMPOSIUM on anti-tumour agents: cytostatic agents.

This publication has 13 references indexed in Scilit:

• Synergism in cancer therapy.
  1956
• Selectivity of Enzyme-Activated Nitrogen Mustards
  Nature, 1956
• Reduction of Cytotoxic Azo Compounds by Hydrazine and by the Xanthine Oxidase–Xanthine System
  Nature, 1955
• STUDIES ON THE ANTI-TUMOUR ACTIVITY OF p-DI-(2-CHLOROETHYL) AMINOPHENYLALANINE (SARCOLYSINE)
  The Lancet, 1955
• THE TOXIC EFFECTS OF 6‐MERCAPTOPURINE AND RELATED COMPOUNDS
  Annals of the New York Academy of Sciences, 1954
• Clinical Effects of the Dichloro and Monochlorophenyl Analogues of Diamino Pyrimidine: Antagonists of Folic Acid12
  Journal of Clinical Investigation, 1954
• MYLERAN IN CHRONIC MYELOID LEUKÆMIA CHEMICAL CONSTITUTION AND BIOLOGICAL ACTION
  The Lancet, 1953
• ANTAGONISTS OF NUCLEIC ACID DERIVATIVES .7. 2,4-DIAMINOPYRIMIDINES
  1952
• A COMPARISON OF THE RETARDATION OF SARCOMA 180 BY SK 1424, 3-BIS (BETA-CHLOROETHYL) AMINOMETHYL-4-METHOXYMETHYL-5-HY-DROXY-6-METHYLPYRIDINE WITH THAT BY HN2, METHYLBIS (BETA-CHLOROETHYL) AMINE
  1951
• A TRIAL OF $beta;-NAPHTHYLDI-2-CHLOROETHYLAMINE (R48) IN LEUKqMIA, HODGKIN'S DISEASE, AND ALLIED DISEASES
  The Lancet, 1950